ID: ALA293277

Max Phase: Preclinical

Molecular Formula: C8H5F3O

Molecular Weight: 174.12

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(c1ccccc1)C(F)(F)F

Standard InChI:  InChI=1S/C8H5F3O/c9-8(10,11)7(12)6-4-2-1-3-5-6/h1-5H

Standard InChI Key:  KZJRKRQSDZGHEC-UHFFFAOYSA-N

Associated Targets(Human)

Anandamide amidohydrolase 3465 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Acyl coenzyme A:cholesterol acyltransferase 1029 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Histone deacetylase 6 20808 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Catharanthus roseus 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Helicobacter pylori 3113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Anandamide amidohydrolase 3907 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 174.12Molecular Weight (Monoisotopic): 174.0292AlogP: 2.43#Rotatable Bonds: 1
Polar Surface Area: 17.07Molecular Species: HBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.66CX LogD: 2.66
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.60Np Likeness Score: -0.69

References

1. Kawase M, Harada H, Saito S, Cui J, Tani S..  (1999)  In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones.,  (2): [PMID:10021926] [10.1016/s0960-894x(98)00726-4]
2. Duran I, Parrilla A, Feixas J, Guerrero A.  (1993)  Inhibition of antennal esterases of the egyptian armyworm Spodoptera littoralis by trifluoromethyl ketones,  (12): [10.1016/S0960-894X(01)80722-8]
3. Kawase M, Sakagami H, Kusama K, Motohashi N, Saito S..  (1999)  Alpha-trifluoromethylated acyloins induce apoptosis in human oral tumor cell lines.,  (21): [PMID:10560735] [10.1016/s0960-894x(99)00548-x]
4. Hamada H, Nakajima N, Shisa Y, Funahashi M, Nakamura K.  (1994)  Enantioselective reduction of ethyl 3-methyl-2-oxobutanoate by an enzymatic system from callus of catharanthus roseus,  (7): [10.1016/S0960-894X(01)80261-4]
5. Boger DL, Miyauchi H, Du W, Hardouin C, Fecik RA, Cheng H, Hwang I, Hedrick MP, Leung D, Acevedo O, Guimarães CR, Jorgensen WL, Cravatt BF..  (2005)  Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.,  48  (6): [PMID:15771430] [10.1021/jm049614v]
6. Wheelock CE, Nakagawa Y, Akamatsu M, Hammock BD..  (2003)  Use of classical and 3-D QSAR to examine the hydration state of juvenile hormone esterase inhibitors.,  11  (23): [PMID:14604674] [10.1016/j.bmc.2003.08.023]
7. Depetter Y, Geurs S, Vanden Bussche F, De Vreese R, Franceus J, Desmet T, De Wever O, D'hooghe M..  (2018)  Assessment of the trifluoromethyl ketone functionality as an alternative zinc-binding group for selective HDAC6 inhibition.,  (6): [PMID:30108990] [10.1039/C8MD00107C]
8. Martin JS, MacKenzie CJ, Fletcher D, Gilbert IH..  (2019)  Characterising covalent warhead reactivity.,  27  (10): [PMID:30975501] [10.1016/j.bmc.2019.04.002]
9. Madden KS, Todd PMT, Urata K, Russell AJ, Vincent KA, Reeve HA..  (2023)  A pharmacophore-based approach to demonstrating the scope of alcohol dehydrogenases.,  83  [PMID:36966660] [10.1016/j.bmc.2023.117255]

Source